News Daily News HFSA 2021 In HF and Diabetes, Mobile Health App Modestly Boosts Physical Activity Michael O'Riordan September 15, 2021
News Daily News Heterozygous FH Diagnosed Late, Remains Undertreated Michael O'Riordan September 13, 2021
News Daily News Could an App Replace Statin Prescribing by Doctors? Michael O'Riordan September 08, 2021
News Daily News From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide L.A. McKeown September 06, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Opinion Editor's Corner ESC 2021 ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress Shelley Wood August 19, 2021
News Daily News Getting More Women in CV Research Will ‘Take a Village’ Yael L. Maxwell August 09, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Daily News Hospital Stays for Meth-Related HF Skyrocket, as Do Costs Caitlin E. Cox July 14, 2021
News Conference News ESC Heart Failure 2021 IRON-CRT: IV Iron Boosts LVEF, Cardiac Contractility in Deficient HF Patients Shelley Wood June 30, 2021
News Daily News No Need to Cool Out-of-Hospital Cardiac Arrest Patients: TTM2 Caitlin E. Cox June 24, 2021
News Daily News LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD Michael O'Riordan June 18, 2021
News Conference News EAS 2021 High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI Michael O'Riordan June 08, 2021
News Conference News EAS 2021 Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI Michael O'Riordan June 07, 2021